These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 31379071)

  • 1. Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.
    Schulert GS; Yasin S; Carey B; Chalk C; Do T; Schapiro AH; Husami A; Watts A; Brunner HI; Huggins J; Mellins ED; Morgan EM; Ting T; Trapnell BC; Wikenheiser-Brokamp KA; Towe C; Grom AA
    Arthritis Rheumatol; 2019 Nov; 71(11):1943-1954. PubMed ID: 31379071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis.
    Chen G; Deutsch GH; Schulert GS; Zheng H; Jang S; Trapnell B; Lee PY; Macaubas C; Ho K; Schneider C; Saper VE; de Jesus AA; Krasnow MA; Grom A; Goldbach-Mansky R; Khatri P; Mellins ED; Canna SW
    Arthritis Rheumatol; 2022 Jul; 74(7):1271-1283. PubMed ID: 35189047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergent high fatality lung disease in systemic juvenile arthritis.
    Saper VE; Chen G; Deutsch GH; Guillerman RP; Birgmeier J; Jagadeesh K; Canna S; Schulert G; Deterding R; Xu J; Leung AN; Bouzoubaa L; Abulaban K; Baszis K; Behrens EM; Birmingham J; Casey A; Cidon M; Cron RQ; De A; De Benedetti F; Ferguson I; Fishman MP; Goodman SI; Graham TB; Grom AA; Haines K; Hazen M; Henderson LA; Ho A; Ibarra M; Inman CJ; Jerath R; Khawaja K; Kingsbury DJ; Klein-Gitelman M; Lai K; Lapidus S; Lin C; Lin J; Liptzin DR; Milojevic D; Mombourquette J; Onel K; Ozen S; Perez M; Phillippi K; Prahalad S; Radhakrishna S; Reinhardt A; Riskalla M; Rosenwasser N; Roth J; Schneider R; Schonenberg-Meinema D; Shenoi S; Smith JA; Sönmez HE; Stoll ML; Towe C; Vargas SO; Vehe RK; Young LR; Yang J; Desai T; Balise R; Lu Y; Tian L; Bejerano G; Davis MM; Khatri P; Mellins ED;
    Ann Rheum Dis; 2019 Dec; 78(12):1722-1731. PubMed ID: 31562126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Lee PY; Schulert GS; Canna SW; Huang Y; Sundel J; Li Y; Hoyt KJ; Blaustein RB; Wactor A; Do T; Halyabar O; Chang MH; Dedeoglu F; Case SM; Meidan E; Lo MS; Sundel RP; Richardson ET; Newburger JW; Hershfield MS; Son MB; Henderson LA; Nigrovic PA
    Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease.
    Brown RA; Henderlight M; Do T; Yasin S; Grom AA; DeLay M; Thornton S; Schulert GS
    Front Immunol; 2018; 9():2995. PubMed ID: 30619348
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Bracaglia C; de Graaf K; Pires Marafon D; Guilhot F; Ferlin W; Prencipe G; Caiello I; Davì S; Schulert G; Ravelli A; Grom AA; de Min C; De Benedetti F
    Ann Rheum Dis; 2017 Jan; 76(1):166-172. PubMed ID: 27296321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings from the 2
    Canna SW; Schulert GS; de Jesus A; Pickering A; Brunner H; Gadina M; Levine S; Goldbach-Mansky R; Boutelle J; Sinha R; DeBenedetti F; Grom A;
    Pediatr Rheumatol Online J; 2020 Jul; 18(Suppl 1):53. PubMed ID: 32664935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
    Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
    Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA).
    Verweyen EL; Schulert GS
    Rheumatology (Oxford); 2022 Mar; 61(3):926-935. PubMed ID: 34459891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome.
    Yasin S; Fall N; Brown RA; Henderlight M; Canna SW; Girard-Guyonvarc'h C; Gabay C; Grom AA; Schulert GS
    Rheumatology (Oxford); 2020 Feb; 59(2):361-366. PubMed ID: 31326996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of interleukin-6, interferon-inducible protein-10 and interleukin-17 in serum and synovial fluid of patients with juvenile idiopathic arthritis].
    Li RJ; Tang XM; Liu W; Zhou J; An YF; Qin SY; Zou ZY
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):472-6. PubMed ID: 24120067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1β and IL-18.
    Rood JE; Rezk A; Pogoriler J; Finn LS; Burnham JM; Josephson MB; Bar-Or A; Behrens EM; Canna SW
    J Clin Immunol; 2023 Jan; 43(1):101-108. PubMed ID: 36006569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-γ hyper-responsiveness and risk for macrophage activation syndrome.
    Schulert GS; Pickering AV; Do T; Dhakal S; Fall N; Schnell D; Medvedovic M; Salomonis N; Thornton S; Grom AA
    Ann Rheum Dis; 2021 May; 80(5):617-625. PubMed ID: 33277241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dysregulated interleukin-18-interferon-γ-CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis.
    Hinze T; Kessel C; Hinze CH; Seibert J; Gram H; Foell D
    Rheumatology (Oxford); 2021 Nov; 60(11):5165-5174. PubMed ID: 33576397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease.
    Aires BP; Wobma H; Samad A; Chandler MT; Chang MH; Dedeoglu F; Fishman MP; Klouda T; Levin J; Halyabar O; Saleeb SF; Tworetzky W; Son MBF; Newburger JW; Casey A; Henderson LA
    J Rheumatol; 2024 Aug; 51(8):811-817. PubMed ID: 38825355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric systemic juvenile idiopathic arthritis-related lung disease: Description of clinical cohort and review of management.
    Swanson C; Khan EK; Cooper A; Ibarra M; Tam-Williams J
    Pediatr Pulmonol; 2024 Mar; 59(3):724-733. PubMed ID: 38155594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-γ is essential for alveolar macrophage-driven pulmonary inflammation in macrophage activation syndrome.
    Gao DK; Salomonis N; Henderlight M; Woods C; Thakkar K; Grom AA; Thornton S; Jordan MB; Wikenheiser-Brokamp KA; Schulert GS
    JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34314387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease.
    Huang Y; Sompii-Montgomery L; Patti J; Pickering A; Yasin S; Do T; Baker E; Gao D; Abdul-Aziz R; Behrens EM; Canna S; Clark M; Co DO; Collins KP; Eberhard B; Friedman M; Graham TB; Hahn T; Hersh AO; Hobday P; Holland MJ; Huggins J; Lu PY; Mannion ML; Manos CK; Neely J; Onel K; Orandi AB; Ramirez A; Reinhardt A; Riskalla M; Santiago L; Stoll ML; Ting T; Grom AA; Towe C; Schulert GS
    Arthritis Care Res (Hoboken); 2024 Mar; 76(3):328-339. PubMed ID: 37691306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung Functioning and Inflammation in a Mouse Model of Systemic Juvenile Idiopathic Arthritis.
    Malengier-Devlies B; Decaesteker T; Dekoster K; Vanstapel A; Ahmadzadeh K; Poosti F; Mitera T; Seldeslachts L; Verbeken E; Wouters C; Vande Velde G; Vanoirbeek J; Matthys P
    Front Immunol; 2021; 12():642778. PubMed ID: 33777039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.